Cold Pain Therapy Market Size Worth USD 2.4 billion by 2027

In 2021, the retail pharmacies segment accounted for the largest share of the cold pain therapy market by distribution channel

According to the new market research report "Cold Pain Therapy Market by Product (OTC (Gels, Creams, Patches, Wraps, Pads), Prescription (Motorized, Non-motorized)), Application (Musculoskeletal, Post-Op, Sports Injuries), Distribution Channel (Hospital, Retail, E-Pharmacy) - Global Forecast to 2027", is projected to reach USD 2.4 billion by 2027 from USD 1.8 billion in 2022, at a CAGR of 5.1%.

Browse in-depth TOC on "Cold Pain Therapy Market"

243 – Tables

42 – Figures

249 – Pages

Download PDF Brochure:

https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=55543905

The rising awareness about the cost-effective cold pain relief products, and rising prevalence of arthritis. Emerging economies such as China, Japan, and India are providing profitable opportunities for the players operating in the cold pain therapy market.

The OTC products segment accounted for the largest share of the cold pain therapy industry, by product segment, in 2021

The cold pain therapy market is segmented into OTC products and prescription products. The OTC products holds the largest share of the cold pain therapy market in 2021, mainly due to the presence of substantial clinical evidence in favor of cooling gels as sports medicine.

Musculoskeletal disorders segment to register the highest growth rate during the forecast period

The cold pain therapy market has been segmented into musculoskeletal disorders, sports medicine, post-operative therapy, and post-trauma therapy. In 2021, the musculoskeletal disorders segment accounted for the largest share of the cold pain therapy market. Factors such as rising geriatric population due to ehich there is higher prevalence of musculoskeletal disorders, and increasing self-care awareness will drive the growth of this segment.

Request Sample Pages:

https://www.marketsandmarkets.com/requestsampleNew.asp?id=55543905

The retail pharmacies segment accounted for the largest share of the cold pain therapy, by distribution channel segment, in 2021

Based on the distribution channel, the cold pain therapy market has been segmented into hospital pharmacies, retail pharmacies, and e-pharmacies. In 2021, the retail pharmacies segment accounted for the largest share of the cold pain therapy market. The implementation of government regulations for proper functioning of retail pharmacies is driving the growth of this segment.

North America is the largest regional market for cold pain therapy market

The global cold pain therapy market is segmented into five major regions—North America, Europe, the Asia Pacific, Latin America, and the Middle East Africa. In 2021, North America accounted for the largest share of the cold pain therapy market. The North American cold pain therapy market growth can be attributed to the growing incidence of arthritis.

The major players operating in this market are Beiersdorf AG (Germany), DJO Global, Inc. (US), Hisamitsu Pharmaceutical Co., Inc. (Japan), Össur (Iceland), Johnson Johnson (US), Pfizer (US), Sanofi (France), Rohto Pharmaceutical (Japan), 3M (US), Cardinal Health Inc. (US), Bird Cronin (US), Compass Health Brands (US), Breg, Inc. (US), Medline Industries (US), Performance Health (US), Romsons Group of Industries (India), Unexo Life Sciences (India), Polar Products (US), Rapid Aid (Canada), Mueller Sports Medicine (US), Pic Solution (US), Bruder Healthcare Company (US), Brownmed Inc. (US), Medichill (Australia), and ThermoTek, Inc. (US).

Market Growth Drivers

  • Increasing incidence of sports injuries and rising emphasis on exercise and gym activities
  • Growing number of hip and knee surgeries across the globe
  • Rising geriatric population and subsequent growth in the prevalence of bone diseases and trauma injuries
  • Growing need for safer pain management modalities as opposed to oral drug therapy
  • Clinical evidence in favor of menthol-based topical analgesics

Market Restraints

  • Wide use of low-priced analgesic pills for immediate pain relief
  • Lack of substantial clinical evidence and reimbursement in favor of cold pain therapy
  • Health hazards and discomfort associated with cold pain therapy products

Market Opportunities

  • Growing adoption of analgesic patches
  • Growing use of cold pain therapy among middle-aged women
  • Increasing regulatory barriers for oral pain medications

Market Challenges

  • Availability of alternative non-drug/device pain management therapies

Get 10% Free Customization on this Report:

https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=55543905

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies' revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model - GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets's flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:

Mr. Aashish Mehra

MarketsandMarkets™ INC.

630 Dundee Road

Suite 430

Northbrook, IL 60062

USA: 1-888-600-6441

Email: [email protected]


Healthcare101

248 Blog posts

Comments